https://www.selleckchem.com/products/sgi-110.html
Our findings suggest that lockdown has a positive impact on glycemic control in people with type 1 diabetes. Real-time continuous glucose monitoring (rtCGM) in critically ill hospitalized patients holds promise; however, real-world data are needed. We placed Dexcom G6 CGM on intensive care unit (ICU) patients at Montefiore Medical Center with confirmed coronavirus disease 2019 (COVID-19) infection and glycemic variability. We analyzed inpatient CGM accuracy using point-of-care (POC) glucose-CGM matched pairs and included patients for an
Like
Comment
Share
